Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) — Financial Flexibility Index
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) has a Financial Flexibility Index of -0.01x as of June 2023. Free cash flow of €-43.91 Million (operating CF €-64.53 Million minus capex €20.62 Million) represents 0% of total liabilities (€3.97 Billion). Also explore 2TZ year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited across 13 annual periods. Check asset allocation strategy of Tianjin Zhong Xin Pharmaceutical Group C to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2013–2025)
Year-by-year free cash flow to debt coverage for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited. For the full company profile including market capitalisation, see Tianjin Zhong Xin Pharmaceutical Group C market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.13x | €579.68 Million | €461.07 Million | €4.59 Billion | ▼ -64.6% |
| 2024 | 0.36x | €1.04 Billion | €924.67 Million | €2.92 Billion | ▲ +54.4% |
| 2023 | 0.23x | €829.42 Million | €688.49 Million | €3.58 Billion | ▲ +6.2% |
| 2022 | 0.22x | €785.15 Million | €677.25 Million | €3.61 Billion | ▼ -44.9% |
| 2021 | 0.40x | €1.01 Billion | €852.40 Million | €2.55 Billion | ▲ +7.2% |
| 2020 | 0.37x | €860.58 Million | €671.42 Million | €2.33 Billion | ▲ +22.0% |
| 2019 | 0.30x | €701.10 Million | €495.49 Million | €2.32 Billion | ▲ +17.8% |
| 2018 | 0.26x | €525.95 Million | €350.14 Million | €2.05 Billion | ▲ +363.5% |
| 2017 | 0.06x | €110.45 Million | €-3.97 Million | €2.00 Billion | ▼ -78.7% |
| 2016 | 0.26x | €533.98 Million | €417.77 Million | €2.06 Billion | ▲ +12.4% |
| 2015 | 0.23x | €453.22 Million | €360.58 Million | €1.96 Billion | ▲ +61.0% |
| 2014 | 0.14x | €357.01 Million | €286.85 Million | €2.49 Billion | ▲ +34.8% |
| 2013 | 0.11x | €285.86 Million | €213.44 Million | €2.69 Billion | — |